The Regulator

5.76 million dollars: that is how much prosecutors say Pennsylvania home-care aides and agencies billed Medicaid for schemes including one aide who kept billing while incarcerated, the debut case for a new Justice Department fraud unit permanently embedded in Philadelphia. The Department of Justice announced August 4, 2026 that federal and state authorities charged 19 defendants in Medicaid home health care fraud schemes across the Eastern District of Pennsylvania, unveiling the office alongside the new District Anti-Fraud Initiative, which embeds agents from the National Fraud Enforcement Division’s Northeast Health Care Fraud Strike Force inside the U.S. Attorney’s Office there. Officials described claims submitted while an aide was incarcerated or hospitalized and more than 8,700 hours of alleged overlapping work by different aides for the same beneficiaries; Assistant Attorney General Colin M. McDonald said “home care funding exists to assist America’s elderly and most vulnerable, not to fund schemes in which aides claim to be providing care while incarcerated or vacationing in Miami and Saudi Arabia,” while law firm Holland & Knight said the Philadelphia office is meant as a template for similar embeds nationwide, where the broader Strike Force model has now prosecuted more than 6,200 defendants who billed over $45 billion. Confidence: Medium. The Department of Justice’s own press release could not be independently retrieved this run, a recurring access problem with justice.gov, but the dollar figures, defendant count and quotes are corroborated across independent outlets. Sources: DOJ Announces Expansion of Healthcare Fraud Enforcement in Greater Philadelphia, Holland & Knight, Health care fraud federal officials Pennsylvania, WHYY, DOJ charges 19 in alleged $4 million Philadelphia Medicaid fraud case as fraud strike force tops $45 billion nationally, Washington Examiner.

421 percent: that is how much Medicaid and CHIP spending on autism therapy for children grew from 2021 through 2025, more than six times the 67 percent growth in the number of diagnosed children receiving it. The Centers for Medicare and Medicaid Services announced August 4, 2026 that it released a State Medicaid and CHIP Applied Behavior Analysis Toolkit directing state agencies to tighten oversight of autism therapy billing, citing that spending growth alongside what the agency called inconsistent clinical practices and fraud schemes targeting the program; the toolkit does not cut eligibility, reduce Early and Periodic Screening, Diagnostic and Treatment obligations, or endorse a single treatment approach, and adoption is left to each state. HHS Secretary Robert F. Kennedy Jr. said the recommendations target “fraud schemes that exploit children with autism and misuse funds from American taxpayers.” Confidence: Medium. This run could not independently retrieve CMS’s own press release, but the spending figures and the Secretary’s quote are corroborated by independent reporting citing the agency’s announcement directly. Sources: CMS Launches New State Toolkit to Protect Children with Autism, Strengthen Oversight of Applied Behavior Analysis Services, Centers for Medicare and Medicaid Services, Medicaid tightens oversight of autism therapy providers, UPI.

100 dollars: that is how much less each side now pays to bring a medical billing dispute to a federal arbitrator, after operational reforms to the No Surprises Act’s arbitration system took general effect this week. The Federal Independent Dispute Resolution Operations final rule, issued jointly by the Departments of Health and Human Services, Labor and the Treasury and published in the Federal Register June 4, 2026, cut the administrative fee for filing a dispute from $115 to $15 per party, took general effect August 3, 2026, and revises batching rules, accelerates eligibility determinations and creates a Federal IDR Registry that plans and insurers must join. The process has drawn more than 5.1 million disputes since the No Surprises Act took effect in 2022, far exceeding federal projections, and the rule is meant to clear a backlog both providers and insurers say made arbitration too slow and too expensive to use. Confidence: Medium. This run could not independently retrieve the Federal Register text or CMS’s own fact sheet, both of which blocked automated access, but the fee figures and effective dates are corroborated by independent legal analysis citing the rule directly. Sources: Federal Independent Dispute Resolution Operations, Federal Register, CMS Revamps No Surprises Act IDR: Key Impacts for Providers, Clark Hill.

Two device makers: that is how many companies issued corrections this week for surgical and spinal-anesthesia convenience kits after the anesthetic they contained was recalled over a manufacturing defect linked to infection and meningitis risk. The Food and Drug Administration identified Class I recalls, its most serious category, tied to Huons Bupivacaine Hydrochloride in Dextrose Injection after an FDA inspection of the South Korean manufacturer’s facility found quality problems; Medline Industries and Arrow International, a Teleflex subsidiary, both issued corrections August 3, 2026 instructing hospitals and surgery centers to remove the affected vials and ampules from convenience kits before continued use. The FDA said using the compromised injections risks infection, inflammatory response or reduced anesthetic effectiveness, and in spinal use specifically risks cerebrospinal fluid contamination that can progress to meningitis or encephalitis. Confidence: Medium. This run could not independently retrieve the FDA’s own recall notices, which returned errors on direct access, but the classification, companies and risk description are corroborated by independent reporting citing the agency’s postings directly. Sources: Highest FDA recall issued for certain convenience kits, American Hospital Association, Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, U.S. Food and Drug Administration.

1 billion dollars: that is the federal penalty Missouri risks starting in October 2029 if it cannot cut its Medicaid error rate below 3 percent, a deadline now driving a legislative fight over whether the state’s three private managed-care insurers are worth their overhead. Missouri pays Healthy Blue, part of Elevance Health, Home State Health, part of Centene, and UnitedHealthcare Community Plan a combined $7.6 billion in state and federal funds in fiscal year 2026 to run most of its Medicaid program, and advocates cite state figures showing those insurers’ administrative overhead ran 8.17 percent in fiscal year 2024, well above the roughly 1 to 3 percent Missouri spends administering the medically complex Medicaid populations it manages directly, which the state says saves $259 million a year. State Senator Maggie Nurrenbern said lawmakers need “a real conversation next year as to what we can do to help rein in some costs,” as the state separately budgeted $132 million this year just to implement the One Big Beautiful Bill Act’s new Medicaid requirements. Confidence: Medium. This run could not independently retrieve Missouri Independent’s original reporting, which blocked automated access, but the dollar figures and quotes are corroborated by a Missouri television affiliate’s direct republication of the same reporting. Sources: Amid federal changes, advocates question the role of private insurers in Missouri Medicaid, KOMU.